7 The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Barnhill, 1984, The second-look surgical reassessment of epithelial ovarian carcinoma, Gynecologic Oncology, 19, 148, 10.1016/0090-8258(84)90173-2
Berek, 1983, Survival of patients following secondary cytoreductive surgery in ovarian cancer, Obstetrics and Gynecology, 61, 189
Blythe, 1982, Debulking surgery: does it increase the quality of survival?, Gynecologic Oncology, 14, 396, 10.1016/0090-8258(82)90115-9
Burghardt, 1986, Pelvic lymphadenectomy in operative treatment of ovarian cancer, American Journal of Obstetrics and Gynecology, 155, 315, 10.1016/0002-9378(86)90817-3
Cain, 1986, A review of second-look laparotomy for ovarian cancer, Gynecologic Oncology, 23, 14, 10.1016/0090-8258(86)90110-1
Chen, 1985, Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian cancer, Gynecologic Oncology, 20, 190, 10.1016/0090-8258(85)90141-6
Conte, 1985, Cisplatin, methotrexate and 5-fluorouracil combination chemotherapy for advanced ovarian cancer, Gynecologic Oncology, 20, 290, 10.1016/0090-8258(85)90210-0
Copeland, 1983, Role of ‘third-look’ laparotomy in the guidance of ovarian cancer treatment, Gynecologic Oncology, 15, 149, 10.1016/0090-8258(83)90068-9
Curry, 1981, Second-look laparotomy for ovarian cancer, Gynecologic Oncology, 11, 114, 10.1016/0090-8258(81)90016-0
Dauplat, 1986, Second-look laparotomy in managing epithelial ovarian carcinoma, Cancer, 57, 1627, 10.1002/1097-0142(19860415)57:8<1627::AID-CNCR2820570831>3.0.CO;2-D
Delclos, 1969, Malignant tumors of the ovary managed with postoperative megavoltage irradiation, Radiology, 93, 659, 10.1148/93.3.659
Delgado, 1984, Stage III epithelial ovarian cancer: the role of maximal surgical reduction, Gynecologic Oncology, 18, 290, 10.1016/0090-8258(84)90040-4
Dembo, 1984, Radiotherapeutic management of ovarian cancer, 11, 238
Fisher, 1978, Chemotherapy of ovarian cancer, Surgical Clinics of North America, 58, 143, 10.1016/S0039-6109(16)41441-6
Fuks, 1982, The multimodal approach to the treatment of Stage IV ovarian carcinoma, International Journal of Radiation Oncology, Biology and Physics, 8, 903, 10.1016/0360-3016(82)90098-0
Goldie, 1979, A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate, Cancer Treatment Reports, 63, 1727
Griffiths, 1975, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma, National Cancer Institute Monographs, 42, 101
Griffiths, 1986, Surgery at the time of diagnosis in ovarian cancer, 60
Griffiths, 1979, Role of cytoreductive surgical treatment in the management of advanced ovarian cancer, Cancer Treatment Reports, 63, 235
Griswold, 1986, Success and failure in the treatment of solid tumor. 1. Effects of cyclophosphamide (NSC026271) on primary and metastatic plasmacytoma in the hamster, Cancer Chemotherapy Reports, 52, 345
Hacker, 1983, Primary cytoreductive surgery for epithelial ovarian cancer, Obstetrics and Gynecology, 61, 413
Hainsworth, 1988, Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration, Annals of Internal Medicine, 108, 165, 10.7326/0003-4819-108-2-165
Hoskins, 1987, Cytoreductive surgery in ovarian cancer, vol. 1
Lewis, 1969, Palliative therapy of advanced ovarian cancer, Clinical Obstetrics and Gynecology, 12, 1038, 10.1097/00003081-196912040-00016
Louie, 1986, Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma, Journal of Clinical Oncology, 4, 1579, 10.1200/JCO.1986.4.11.1579
Luesley, 1984, Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of 50 cases, Obstetrics and Gynecology, 64, 421
Maggino, 1983, Role of second-look laparotomy in multidisciplinary treatment and in the follow-up of advanced ovarian cancer, European Journal of Gynecologic Oncology, 4, 26
Moore, 1980, Debunking debulking, Surgery, Gynecology and Obstetrics, 150, 395
Munnell, 1968, The changing prognosis and treatment in cancer of the ovary: a report of 235 patients with primary ovarian carcinoma 1952–1961, American Journal of Obstetrics and Gynecology, 100, 790, 10.1016/S0002-9378(15)33580-8
Neijt, 1984, Randomized trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-S) in advanced ovarian carcinoma, Lancet, ii, 594, 10.1016/S0140-6736(84)90594-4
Neijt, 1987, Randomized trial comparing two combination chemotherapy regimens (CHAPS-5 vs CP) in advanced chemotherapy, Journal of Clinical Oncology, 5, 1157, 10.1200/JCO.1987.5.8.1157
Perez, 1972, Radiation therapy in the treatment of carcinoma of the ovary, Cancer, 29, 1027, 10.1002/1097-0142(197204)29:4<1027::AID-CNCR2820290451>3.0.CO;2-4
Phibbs, 1983, Analysis of sites of persistent cancer at ‘second-look’ laparotomy in patients with ovarian cancer, American Journal of Obstetrics and Gynecology, 147, 611, 10.1016/0002-9378(83)90436-2
Podratz, 1983, Second-look laparotomy in ovarian cancer: evaluation of pathologic variables, American Journal of Obstetrics and Gynecology, 192, 230
Podratz, 1988, Recurrent disease after negative second-look laparotomy in Stages III and IV ovarian carcinoma, Gynecologic Oncology, 29, 274, 10.1016/0090-8258(88)90226-0
Posada, 1985, The cyclophosphamide, hexamethylmelamine, 5-fluorouracil regimen in the treatment of advanced and recurrent ovarian cancer, Gynecologic Oncology, 20, 23, 10.1016/0090-8258(85)90121-0
Raju, 1982, Second-look operations in the planned management of advanced ovarian carcinoma, American Journal of Obstetrics and Gynecology, 144, 650, 10.1016/0002-9378(82)90432-X
Redman, 1986, Prognostic factors in advanced ovarian carcinoma, Journal of Clinical Oncology, 4, 515, 10.1200/JCO.1986.4.4.515
Rubin, 1988, Palliative surgery for intestinal obstruction in advanced ovarian cancer, Gynecologic Oncology
Silverberg, 1988, Cancer statistics, 1988, Ca—A Cancer Journal for Clinicians, 38, 5, 10.3322/canjclin.38.1.5
Smirz, 1985, Second-look laparotomy after chemotherapy in the management of ovarian malignancy, American Journal of Obstetrics and Gynecology, 152, 661, 10.1016/S0002-9378(85)80041-7
Smith, 1979, Review of ovarian cancer at the University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, American Journal of Obstetrics and Gynecology, 135, 984, 10.1016/0002-9378(79)90824-X
Smith, 1976, Second-look operation in ovarian cancer, Cancer, 38, 1438, 10.1002/1097-0142(197609)38:3<1438::AID-CNCR2820380351>3.0.CO;2-2
Sutton, 1986, Seven-year follow-up of patients receiving cisplatin, adriamycin and cyclophosphamide (PAC) chemotherapy for Stage III and IV epithelial ovarian carcinoma, 5, 120
Webb, 1982, Second-look laparotomy in ovarian cancer, Gynecologic Oncology, 14, 285, 10.1016/0090-8258(82)90101-9
Wharton, 1984, Cytoreductive surgery for common epithelial tumors of the ovary, Clinical Obstetrics and Gynecology, 10, 235, 10.1016/S0306-3356(21)00566-5
Wiltshaw, 1985, The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery, British Journal of Obstetrics and Gynaecology, 92, 522, 10.1111/j.1471-0528.1985.tb01359.x
Wu, 1986, Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy, American Journal of Obstetrics and Gynecology, 155, 1103, 10.1016/0002-9378(86)90359-5